Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) is now available.
Sihuan Pharmaceutical Holdings Group Ltd. has announced the basis of assured entitlement for qualifying shareholders in the preferential offering related to the proposed spin-off and separate listing of its subsidiary, Xuanzhu Biopharmaceutical Co., Ltd., on the Hong Kong Stock Exchange. The entitlement is set at one reserved share for every 2,728 shares held as of the record date, with the spin-off subject to approval and market conditions. This move could potentially enhance the company’s market positioning by unlocking value through the separate listing of its biopharmaceutical arm.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd. is a company incorporated in Bermuda, primarily operating in the pharmaceutical industry. It is involved in the development and commercialization of pharmaceutical products, focusing on the Chinese market.
Average Trading Volume: 98,810,504
Technical Sentiment Signal: Buy
Current Market Cap: HK$15.58B
For an in-depth examination of 0460 stock, go to TipRanks’ Overview page.